<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210218050401N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-31</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Effect of acceptance and commitment group counseling  on anxiety and quality of life in pregnant women with hypertensive disorders</public_title>
      <acronym></acronym>
      <scientific_title>Effect of acceptance and commitment group counseling  on anxiety and quality of life in pregnant women with hypertensive disorders</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54476</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: This study will be performed on 60 pregnant women with a gestational age of 24-26 weeks with preeclampsia and gestational hypertension referred to Health Center 2. From this center, two comprehensive health service centers were selected from the total comprehensive health centers covered by it.  They will be.  The two centers will be allocated to intervention (control counseling) and control groups by lottery method.  Patients with preeclampsia and gestational hypertension are identified and listed under those centers using the Sina system.  Sampling will be done by available methods.</study_design>
      <phase>N/A</phase>
      <hc_freetext>on anxiety and quality of life  in pregnant women with hypertensive disorders.</hc_freetext>
      <i_freetext>Intervention 1: Participants in the intervention group are first asked to complete the Personal and Midwifery Profile Form and the Zemen Social Support, Beck Anxiety, Vandenberg Pregnancy Anxiety, and Quality of Life (WHOQOL-BREF) questionnaires.  For the intervention group, eight group counseling sessions (three groups of 10 people) are held by the researcher at intervals of two sessions per week in the form of questions and answers, a dynamic and active relationship between the counselor and the participants. The duration of each session will be 45-60 minutes.  .  The first counseling session is held in person in the center's classroom, and the next seven sessions are conducted virtually via Skyroom.  The first session includes group members getting to know each other and greeting each other, explaining the group rules, explaining about pregnancy, getting acquainted with the counseling approach, explaining suffering, the second session: living in the present and mindfulness, the third session: avoiding experience  Session 4: Acceptance, Session 5: Failure, Session 6: Self as context, Session 7: Values, Session 8: Commitment and mindfulness practice focusing on the end of counseling and finally the questionnaires completed by pregnant women  Be.  A file of summary sessions for practice at home is also provided. Training and routine intervention intervention group (assessment of blood pressure, weight, fetal heart rate and fetal growth monitoring from uterine height. Training and routine follow-up according to gynecologist feedback or  Maternity hospitals will receive telephone follow-up if not referred by health care providers and midwives. One month after the intervention, the Vandenberg Pregnancy Anxiety Questionnaire (WHOQOL-BREF quality of life questionnaire) will be completed for intervention group. Intervention 2: Control group: Participants in the control group are asked to complete the Personal and Midwifery Profile Form and the Siemens Social Support, Beck Anxiety, Vandenberg Pregnancy Anxiety, and Quality of Life (WHOQOL-BREF) questionnaires.  Routine training and care (assessment of blood pressure, weight, fetal heartbeat and fetal growth monitoring from uterine height, routine training and follow-up according to gynecologist or maternity ward feedback if telephone follow-up is not provided) by health care providers and midwives  One month after the intervention, the Vandenberg Pregnancy Anxiety Questionnaire (WHOQOL-BREF) will be completed for the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals

When:
Access period starts 6 months after the results are published

To whom:
Researchers and students of academic institutions

Conditions:
Based on the present study and without changes in the data

Where to obtain:
Contact the author responsible for responding via email or phone khazaey1270@gmail.com Phone: 00989158200204

How to obtain:
The request for access to data / documents will be reviewed by the research team

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Samane Khazaei Fadafan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Ibn Sina St, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Khazaeifs981@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid Jahani Shoorab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Ibn Sina St, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>0096 51 38591511</telephone>
        <email>Jahanishn@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being Iranian
Having at least a cycle of education
Non-smoking and alcohol
Having a smartphone with Android operating system or IOS system
Get a score less than 26 from the Beck Anxiety Questionnaire
Pregnancy age 24-26 weeks
Pregnancy hypertension or Non-severe preeclampsia (based on patient records)
Single pregnancies
No chronic underlying diseases and medical and obstetric complications
No history of mental disorders and no hospitalization during recent pregnancy</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Reluctance to participate in research
Failure to participate in more than two sessions of counseling
medical and obstetric complications during research that requires pharmacological medical interventions
Existence of family disputes during the study
Occurrence of adverse events during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O10- O16</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>edema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Participants in the intervention group are first asked to complete the Personal and Midwifery Profile Form and the Zemen Social Support, Beck Anxiety, Vandenberg Pregnancy Anxiety, and Quality of Life (WHOQOL-BREF) questionnaires.  For the intervention group, eight group counseling sessions (three groups of 10 people) are held by the researcher at intervals of two sessions per week in the form of questions and answers, a dynamic and active relationship between the counselor and the participants. The duration of each session will be 45-60 minutes.  .  The first counseling session is held in person in the center's classroom, and the next seven sessions are conducted virtually via Skyroom.  The first session includes group members getting to know each other and greeting each other, explaining the group rules, explaining about pregnancy, getting acquainted with the counseling approach, explaining suffering, the second session: living in the present and mindfulness, the third session: avoiding experience  Session 4: Acceptance, Session 5: Failure, Session 6: Self as context, Session 7: Values, Session 8: Commitment and mindfulness practice focusing on the end of counseling and finally the questionnaires completed by pregnant women  Be.  A file of summary sessions for practice at home is also provided. Training and routine intervention intervention group (assessment of blood pressure, weight, fetal heart rate and fetal growth monitoring from uterine height. Training and routine follow-up according to gynecologist feedback or  Maternity hospitals will receive telephone follow-up if not referred by health care providers and midwives. One month after the intervention, the Vandenberg Pregnancy Anxiety Questionnaire (WHOQOL-BREF quality of life questionnaire) will be completed for intervention group</i_keyword>
      <i_keyword>Control group: Participants in the control group are asked to complete the Personal and Midwifery Profile Form and the Siemens Social Support, Beck Anxiety, Vandenberg Pregnancy Anxiety, and Quality of Life (WHOQOL-BREF) questionnaires.  Routine training and care (assessment of blood pressure, weight, fetal heartbeat and fetal growth monitoring from uterine height, routine training and follow-up according to gynecologist or maternity ward feedback if telephone follow-up is not provided) by health care providers and midwives  One month after the intervention, the Vandenberg Pregnancy Anxiety Questionnaire (WHOQOL-BREF) will be completed for the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pregnancy Related Anxiety Questionnaire score. Timepoint: Before starting the information, end of intervention and One month later. Method of measurement: Vandenberg Pregnancy Related Anxiety Questionnaire.</prim_outcome>
      <prim_outcome>WHO Quality of Life BREF Questionnaire Score. Timepoint: Before starting the information, end of intervention and One month later. Method of measurement: WHO Quality of Life BREF Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-10</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Mashhad Ibn Sina St., School of Nursing and Midwifery mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
